Clinical and Radiological Fusion: A New Frontier in Predicting Post-Transplant Diabetes Mellitus
Transplant International · 03.04.2025 · 38
DOI: 10.3389/ti.2025.14377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, online erschienen am 03.04.2025. Verfasst von Pooja Budhiraja und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, United States. Hauptthemen laut MEDLINE: Kidney Transplantation, Diabetes Mellitus, Postoperative Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
This study developed a predictive model for Post-Transplant Diabetes Mellitus (PTDM) by integrating clinical and radiological data to identify at-risk kidney transplant recipients. In a retrospective analysis across three Mayo Clinic sites, clinical metrics were combined with deep learning analysis of pre-transplant CT images, focusing on body composition parameters like adipose tissue and muscle mass instead of BMI or other biomarkers. Among 2,005 nondiabetic kidney recipients, 335 (16.7%) developed PTDM within the first year. PTDM patients were older, had higher BMIs, elevated triglycerides, and were more likely to be male and non-White. They exhibited lower skeletal muscle area, greater visceral adipose tissue (VAT), more intermuscular fat, and higher subcutaneous fat (all p < 0.001). Multivariable analysis identified age (OR: 1.05, 95% CI: 1.03–1.08, p < 0.0001), family diabetes history (OR: 1.55, CI: 1.14–2.09, p = 0.0061), White race (OR: 0.43, CI: 0.28–0.66, p < 0.0001), and VAT area (OR: 1.37, CI: 1.14–1.64, p = 0.0009) as predictors. The combined model achieved C-statistic of 0.724 (CI: 0.692–0.757), outperforming the clinical-only model (C-statistic 0.68). Patients with PTDM in the first year had higher mortality than those without PTDM. This model improves predictive precision, enabling accurate identification and intervention for at risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, United States.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.
- Department of Medicine, Mayo Clinic, Rochester, MN, United States.
- Department of Radiology, Mayo Clinic, Rochester, MN, United States.
- Department of Surgery, Mayo Clinic, Rochester, MN, United States.
- Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, United States.
Zitieren
APA
Budhiraja, P., Smith, B. H., Kukla, A., Kline, T. L., Korfiatis, P., Stegall, M. D., Jadlowiec, C. C., Cheungpasitporn, W., Wadei, H. M., Kudva, Y. C., Alajous, S., Misra, S. S., Me, H. M., Rios, I. P., & Chakkera, H. A. (2025). Clinical and Radiological Fusion: A New Frontier in Predicting Post-Transplant Diabetes Mellitus. Transplant International, 38. https://doi.org/10.3389/ti.2025.14377
Vancouver
Budhiraja P, Smith BH, Kukla A, Kline TL, Korfiatis P, Stegall MD, et al. Clinical and Radiological Fusion: A New Frontier in Predicting Post-Transplant Diabetes Mellitus. Transplant International. 2025;38. doi:10.3389/ti.2025.14377
BibTeX
@article{Budhiraja2025,
author = {Budhiraja, Pooja and Smith, Byron H and Kukla, Aleksandra and Kline, Timothy L and Korfiatis, Panagiotis and Stegall, Mark D and Jadlowiec, Caroline C and Cheungpasitporn, Wisit and Wadei, Hani M and Kudva, Yogish C and Alajous, Salah and Misra, Suman S and Me, Hay Me and Rios, Ian P and Chakkera, Harini A},
title = {Clinical and Radiological Fusion: A New Frontier in Predicting Post-Transplant Diabetes Mellitus},
journal = {Transplant International},
year = {2025},
volume = {38},
doi = {10.3389/ti.2025.14377}
}
EUVIMED